AUGUST 2022LIFE SCIENCES REVIEW6The global clinical trial patient recruitment services market size is expected to reach USD 1.56 billion by 2030 witnessing a CAGR of 8.0 percent during the forecast period. The growing pharmaceutical and medical sectors, increasing demand for clinical studies, and adoption of decentralized clinical trials are a few of the factors supporting the growth of the clinical trial patient recruitment services market.However, the COVID-19 pandemic has affected the global market; the outbreak of COVID-19 has caused a voluntary pause in the clinical trials across the globe. The temporary lockdown has significantly disrupted clinical trials, especially in the patient recruitment industry. The lockdown has restricted the patient's visits to trial sites, which has ultimately led to significant dropouts of the patient population from several clinical trials.Technology is constantly evolving, but many potential participants still prefer to speak with someone on the phone, especially when it comes to sensitive medical topics. While digital has trended up, the pandemic has also highlighted the need for human connection in medicine more than ever before. Sponsors and sites should be thinking about adding follow-up services that are automated, personal, and also human.Automated follow-up emails or text messages can remind patients to take the next step. But it's also key to maintain a human connection throughout the clinical trial process.While technology will continue to provide important and impactful solutions within medical research, it's essential to remember that taking part in a clinical trial is a major decision that often requires an element of human contact, not just automation. When it comes to actually running a clinical trial, researchers have been getting creative, trading traditional processes for virtual or decentralized opportunities. One major advantage of decentralized trials is that they minimize health risks for patients taking part, many of whom have conditions that make them especially vulnerable to COVID-19. This benefit removes the burden and any accompanying anxieties from patients and encourages participation from wherever they may be.Let us know your thoughts.EDITORIALThe Evolving Space of Patient RecruitmentCopyright © 2022 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com AUGUST - 08 - 2022, Vol 03, Issue - 17 (ISSN 2831-8331) Published by ValleyMedia, Inc.To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com Editorial StaffAaron PierceCarolynn WaltersShirley FaithRussell ThomasCatalina Joseph Clara MatthewVisualizersRonald DonovanDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsSalesStephen Thomassales@lifesciencesreview.comVictor Cruz
< Page 5 | Page 7 >